Cancer Horizons logo
Select a Cancer Type:

Leukemia

Leukemia

RELATED ARTICLES

What to Expect With a Stem Cell Transplant for Leukemia
What to Expect With a Stem Cell Transplant for Leukemia
Dr. Partow Kebriaei explains what patients can expect before, during and after an allogeneic stem cell transplant to treat acute lymphoblastic leukemia.
Advancing CML Management Towards an Ideal Patient Journey
Advancing CML Management Towards an Ideal Patient Journey
The panel concludes its discussion with insights on challenges and unmet needs in the CML treatment landscape, highlighting ways to better support patients and caregivers.
Ensuring Informed CML Care from Diagnosis Onward
Ensuring Informed CML Care from Diagnosis Onward
Experts on chronic myeloid leukemia delve into the important role of informed shared decision-making in the optimal treatment of patients with CML.
CML Treatment: Scenarios that Necessitate Switching Therapy
CML Treatment: Scenarios that Necessitate Switching Therapy
Jorge E. Cortes, MD, details clinical scenarios that indicate a need to switch therapies for patients with chronic myeloid leukemia.
When CML Therapy Shifts: Collaborative Approaches to Treatment Changes
When CML Therapy Shifts: Collaborative Approaches to Treatment Changes
Claire Saxton shares insights on how physicians and caregivers can best assist patients with CML who have switched therapies.
Open Dialogue in CML Care: Setting Expectations, Managing Side Effects, and Optimizing Patient Quality of Life
Open Dialogue in CML Care: Setting Expectations, Managing Side Effects, and Optimizing Patient Quality of Life
A panel of experts on chronic myeloid leukemia discuss common patient concerns, adverse effect considerations, and best practices for setting clear expectations.
Starting CML Treatment: Collaborative Choices for Better Outcomes
Starting CML Treatment: Collaborative Choices for Better Outcomes
Focusing on the initiation of treatment for newly diagnosed patients with CML, Jorge E. Cortes, MD, details important factors to consider when starting treatment and Claire Saxton discusses strategies that optimize communication when considering treatment options.
Empowering CML Caregivers: Strategies and Support Systems
Empowering CML Caregivers: Strategies and Support Systems
Experts on chronic myeloid leukemia discuss how caregivers can collaborate with the health care team and support newly diagnosed patients.
Sponsored DTC Video
Sponsored DTC Video
Knowing MRD Status Can ‘Increase Chance of Cure’ in Blood Cancer
Knowing MRD Status Can ‘Increase Chance of Cure’ in Blood Cancer
What Is CAR-T Cell Therapy, and What Can Patients With Cancer Expect?
What Is CAR-T Cell Therapy, and What Can Patients With Cancer Expect?
Over the past five years, CAR-T cell therapy has improved outcomes for many patients with blood cancer. Here’s what patients need to know about the immune-based treatment.
The 'Flipside' of Tumor Lysis Syndrome Shows Efficacy in Leukemia, Lymphoma
The 'Flipside' of Tumor Lysis Syndrome Shows Efficacy in Leukemia, Lymphoma
Although tumor lysis syndrome may be dangerous and fatal if not treated early, experts note that it is a sign of successful treatment in patients with leukemia and lymphoma.
FDA OKs Continued Enrollment in Ongoing Blood Cancer Clinical Trials After Gilead Addresses Safety Concerns
FDA OKs Continued Enrollment in Ongoing Blood Cancer Clinical Trials After Gilead Addresses Safety Concerns
Earlier in the year, clinical trials assessing magrolimab for myelodysplastic syndrome and acute myeloid leukemia were put on a partial clinical hold, but now the FDA said that they can start enrolling patients again.
New Treatments Lend a Positive Outlook to Patients With GVHD
New Treatments Lend a Positive Outlook to Patients With GVHD
There are now more drugs than ever to treat and prevent graft-versus-host disease in patients with blood cancer who receive a stem cell transplant.
Trial Initiated to Study Protein-Inhibiting Treatment Option for Patients With Acute Leukemia
Trial Initiated to Study Protein-Inhibiting Treatment Option for Patients With Acute Leukemia
A trial to examine BMF-219 in patients with relapsed or refractory acute leukemias has begun recruiting patients across multiple U.S. states.
Leukemia Risk Factors
Leukemia Risk Factors
Is there anything that we can do to lessen our child’s risk of developing this terrible disease? Let’s talk today about leukemia risk factors and its effect on kids